GILLIAN C IVERS-READ Insider Trading
Get free email notifications about insider trading for GILLIAN C IVERS-READ.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GILLIAN C IVERS-READ. GILLIAN C IVERS-READ is a Vice President in PHARMION CORP ($PHRM) and a VP, Clin. Dev. & Reg. Affairs in PHARMION CORP ($PHRM) and a VP-Clinical Dev.& Reg. Affairs in PHARMION CORP ($PHRM) and a Director in BIO-PATH HOLDINGS INC ($BPTH) and a See Remarks in Clovis Oncology, Inc. ($CLVS).
Address: C/O PHARMION CORPORATION 2525 28TH STREET BOULDER 80301 CO
Companies in which GILLIAN C IVERS-READ is an Insider
BIO-PATH HOLDINGS INC
Trading Symbol: BPTHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GILLIAN C IVERS-READ: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 17 2011
$BPTH Market Capitalization: $81.31M
$BPTH Previous Close: $0.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Clovis Oncology, Inc.
Trading Symbol: CLVSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GILLIAN C IVERS-READ: See Remarks
Holdings: 248,828 shares
Current Value: $14,929,680
Latest Transaction: May 04 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PHARMION CORP
Trading Symbol: PHRMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GILLIAN C IVERS-READ: VP-Clinical Dev.& Reg. Affairs, VP, Clin. Dev. & Reg. Affairs, Vice President
Holdings: 0 shares
Latest Transaction: Dec 14 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GILLIAN C IVERS-READ
Sentiment: All, BPTH, CLVS, PHRM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 4,625 | 0 | 50,875 | |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 3,749 | 0 | 26,245 | |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.54 | 2,183 | 12,094 | 249,501 | 251.7 K to 249.5 K (-0.87 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 4,625 | 0 | 251,684 | 247.1 K to 251.7 K (+1.87 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.54 | 1,769 | 9,800 | 247,059 | 248.8 K to 247.1 K (-0.71 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 3,749 | 0 | 248,828 | 245.1 K to 248.8 K (+1.53 %) |
Dec 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 0 |